Company: RGNT
Filing Date: 2025-01-24
Form Type: DRS
Source: 0001213900-25-006245
Chunk: 188

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-24
Form: DRS
Chunk 188
---
 $835,000. In connection with the 2021 CLAs, the lenders were granted warrants to purchase shares of the Company of the same
class of the conversion securities. Effective as of March 11, 2024, the 2021 CLAs were converted into 35,354 Ordinary Shares and the
warrants granted thereunder expired in full in December 2023.

Between August 2020 and February
2021, we entered into the 2020 CLAs, pursuant to which we obtained a convertible loan in the aggregate amount of $900,000. The 2020 CLAs
have been extended until August 31, 2025. In October 2024, or the October 2024 Addendum, we proposed to the lenders under the 2020 CLAs
to increase principal amount under their respective portion of the 2020 CLA, up to an additional aggregate amount of $450,000, so that
the 2020 CLAs shall bear interest at 8% per annum until maturity commencing as of July 1, 2024 with respect to non-participating lenders
and March 31, 2025 with respect to participating lenders. In addition, pursuant to the October 2024 Addendum, we agreed to pay the participating
lenders at maturity an additional aggregate amount of 340,000 as a risk premium, and upon the occurrence of an initial public offering
based on a pre money valuation of $5.15 million, the 2020 CLAs shall be automatically converted into 243,955 Ordinary Shares and the
Additional Amount in addition to the risk premium and the Interest Amount (each as defined therein) shall be automatically converted
into 221,456 Ordinary Shares.

Other Financings

Between October 2024 and November 2024, we entered into bridge loan agreements, or the Bridge Loans, pursuant to which we obtained a bridge loan from the lenders thereto including certain related parties. The Bridge Loans shall bear interest at 8% per annum until maturity and we agreed to pay the lenders an additional risk premium equal to 30% of their respective loan amount. In October 2024, we amended the Bridge Loans pursuant to which the Bridge Loans may be extended beyond March 31, 2025 and until June 30, 2025, subject to the Registration Statement effectiveness not later than March 31, 2025 and the fulfillment of additional cumulative conditions. Furthermore, upon the occurrence of a Qualifying